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Introduction 
External beam radiation therapy (EBRT) is 
considered to be one of the options to treat the 
prostate cancer. Due to advanced development in 
EBRT such as volumetric modulated arc therapy 
(VMAT) and intensity modulated radiation therapy 
(IMRT), it is possible to deliver conformal dose to the 
target while minimizing dose to the organs at risk 
(OAR). The VMAT can deliver modulated radiation 
beam with simultaneous adjustment of dose rate, 
gantry speed, and multi leaf collimator (MLC) field 
aperture [1]. In IMRT, radiation beam is either 
divided into smaller segments of differing MLC 
shape such as in the case of static IMRT or modulated 
by continuously moving MLC such as in the case of 
dynamic IMRT [1, 2]. A number of studies have 
reported the use of VMAT and IMRT for the prostate 
cancer. The purpose of this study is to review the 
current literature on VMAT and IMRT for prostate 
cancer. A literature search was conducted using 
PubMed and Google Scholar with keywords “prostate 
cancer”, “IMRT”, and “VMAT”.  
Literature Review 
Several authors have reported planning studies on VMAT 
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Abstract  
Volumetric intensity-modulated arc therapy (VMAT) is gaining popularity to treat the prostate 
cancer. The main aim of this article is to review the current literature on VMAT and intensity 
modulated radiation therapy (IMRT) planning for prostate cancer, and highlights several factors 
which can influence the dosimetric results. 
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vs. IMRT for prostate cancer. Palma et al. [3] compared the 
IMRT with constant dose rate (cdr)-VMAT and 
variable-dose rate (vdr)-VMAT for 10 prostate cancer 
patients. It was reported that, in comparison to the IMRT, 
the vdr-VMAT technique produced more favorable dose 
distributions and reduced number of monitor units (MUs). 
Zhang et al. [4] compared the VMAT with IMRT for 11 
prostate cancer patients, and reported that the VMAT 
technique was better at sparing rectal wall, with a reduction 
of beam on time by up to 55% while maintaining 
dosimetric results compared to that of IMRT. 
Kjaer-Kristoffersen et al. [5] performed the dosimetric 
study on 8 prostate cancer patients, and the study showed 
that the VMAT technique produced better or equal sparing 
of the critical structure than the IMRT, with higher MUs in 
the IMRT plans. Similarly, Hardcastle et al. [6] reported 
reductions in rectal doses for all 10 prostate cancer patients 
using VMAT, with significant reduction in MUs and 
delivery time when compared to the IMRT. Table 1 shows 
the average treatment delivery times found among various 
prostate cancer treatment planning studies. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 An example of beam set up for IMRT (top) and VMAT (bottom) 
 
In another planning study by Ost et al. [7], dosimetric 
comparison was done between the VMAT and IMRT plans 
for 12 prostate cancer patients with an objective of dose 
escalation to the intraprostatic lesion. Ost et al. [7] 
concluded that the VMAT allowed for dose escalation to the 
IPL with better sparing of the rectum than the IMRT. Kopp 
et al. [8] compared the VMAT with IMRT for 292 prostate 
cancer patients, and reported that the VMAT was superior 
to the IMRT, especially for the critical structures, without 
compromising coverage to the planning target volume 
(PTV).  However, few other treatment planning studies 
have shown that the IMRT could result superior dosimetric 
results than the VMAT, especially for the OARs. For 
instance, Yoo et al. [9] compared the IMRT with VMAT for 
10 prostate cancer patients, and reported that the IMRT was 
better in sparing bladder, rectum, and small bowel than the 
VMAT when PTV included prostate, seminal vesicles, and 
lymph nodes. Wolff et al. [10] compared the VMAT with 
IMRT and found lower mean dose to the rectum in the 
IMRT plans than in the VMAT plans. In contrast, Rao et al. 
[11] showed that the VMAT was better at normal tissue 
sparing as compared with the IMRT. Tsai et al. [12] study 
on 12 prostate cancer patients showed that VMAT had only 
slight dosimetric advantage over the IMRT. Shaffer et al. 
[13] investigate the simultaneous integrated boost (SIB) 
technique in VMAT and IMRT plans for 10 prostate cases, 
and the study concluded that the VMAT was able to boost 
more of the clinical target volume (CTV) than IMRT with 
doses to the OARs within acceptable limit.  
Several planning studies have also investigated the planning 
techniques in VMAT using either single arc (SA), double 
arc (DA), partial SA (p-SA), or partial-DA (p-DA). 
Recently, Rana et al. [14] showed that both the DA and 
p-DA techniques produced more conformal and less 
heterogeneous plans, with better sparing of rectum and 
bladder when compared with the SA technique.  Rana et al. 
[14] also showed that the p- DA technique was better than 
the standard DA (with full gantry rotation) in terms of 
sparing of the rectum and bladder, but no clear dosimetric 
differences was observed between these two techniques for 
dose conformity and target heterogeneity. In another study 
by Rana et al. [15], it was reported that, for the identical 
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PTV coverage, p-SA was better than the standard SA (one 
full gantry rotation) resulting lower doses to the rectum and 
bladder, but for the higher femoral head dose and integral 
dose in the p-SA plans. The radiobiological study [16] 
comparing SA and DA techniques for prostate cancer 
showed that DA resulted lower normal tissue complication 
probability (NTCP) whereas the NTCP for other structures 
(bladder and femoral heads) and tumor control probability 
(TCP) for prostate tumor were comparable. The current 
literature on planning studies comparing SA and DA has 
also shown some inconsistence in terms of dosimetric 
results. For instance, Sze et al. [17] reported that the SA 
technique resulted smaller volume of bladder exposed at 
70Gy and 20Gy, whereas Rana et al. [14] showed that SA 
always produced higher doses to the bladder. Wolff et al. 
[10] reported no significant difference in dosimetric quality 
between DA and SA techniques. Guckenberger et al. [18] 
showed that SA technique yielded lower dose to the rectum.  
  The contradictory dosimetric results among treatment 
planning studies are mainly attributed to variations in terms 
of treatment planning systems (TPS), beam parameters, 
treatment delivery, and plan optimization techniques. For 
instance, commercial TPS from different vendors employ 
different dose calculation and optimization algorithms, and 
the prostate treatment plans optimized and/or calculated by 
different algorithms will typically result different dosimetric 
results as shown by Rana et al. [19]. This is mainly due to 
difference in beam modeling approach within the dose 
calculation and plan optimization algorithms. Furthermore, 
since prostate cancer involves heterogeneities such as 
femoral heads along the radiation beam path, dosimetric 
results may vary depending upon the heterogeneity 
corrections employed within the dose calculation 
algorithms [19-22]. Thus, planning studies utilizing 
different dose calculation algorithms may produce different 
dosimetric results for the prostate cancer.  
 
Table 1 Summary of average treatment delivery times between IMRT and VMAT in various treatment planning 
studies of prostate cancer 
 Average treatment delivery times 
References VMAT IMRT 
Sze et al. [17] 1.30 min (Single Arc); 
2.78 min (Double Arc) 
4.80 min (7 field) 
Zhang et al. [4] 1 min (Single Arc) 5 min (5 field) 
Hardcastle et al. [6] 1.3 min (Single Arc) 4.5 min (5 field) 
Ost et al. [7] 1.95 min (Single Arc) 4.82 min (7 field); 
3.85 min (5 field) 
Yoo et al. [9] 1.5 min (Single Arc) 
3.1 min (Double Arc) 
8.1 min (9 field); 
4.9 min (7 field) 
Guckenberger et al. [18] 2.08 min (Single Arc); 
3.87 min (Double Arc) 
5.82 min (7 field) 
Shaffer et al. [13] 3.7 min (Single Arc) 9.6 min (9 field) 
Tsai et al. [12] 2.6 min (Single Arc) 3.8 min (5 field) 
Rao et al. [11] 2.2 min (Single Arc) 8.1 min (7 field) 
Wolf et al. [10] 1.8 min (Single Arc); 
3.7 min (Double Arc) 
6 min (7 field) 
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The number of arcs used in VMAT can also influence in the 
dosimetric results of prostate cancer. The SA VMAT plan 
has less control points when compared to the DA VMAT 
plan, and more control points typically result higher degree 
of modulation producing better plan quality. However, it is 
essential to note that highly modulated treatment plans are 
associated with longer plan optimization, and this could be a 
hindrance if the limited planning resources are available in 
the clinic.  Additionally, the design of treatment machine 
head can also affect the OAR dose due to variability in 
secondary collimator transmission and scatter radiation of 
the machines from different vendors.  
  Another factor that can influence on the dosimetric 
results is the experience of a treatment planner, especially 
during the plan optimization process. As a part of plan 
optimization process, a treatment planner has to select the 
dose constraints and objectives for the target volume and 
each OAR. The dosimetric results as a result of plan 
optimization are dependent on the optimization parameters 
and method of optimization. Hence, it is possible that the 
difference in plan optimization techniques may have 
contributed to the inconsistencies in the findings among 
different planning studies.  
  Treatment outcome of patients is very important to 
ensure the safety of treatment technique. For IMRT, it was 
reported that high radiation dose delivered to small volume 
of rectum is the primary cause of toxicities or late rectal 
bleeding. For rectum, studies recommend that relative 
volume receiving 70 Gy (V70Gy) must be less than 20% of 
total rectal volume [23], whereas the dose constraint for the 
bladder [24] is V70Gy must be less than 35%. Treatment 
outcome with long term follow up for patients treated with 
VMAT is yet to be reported.  
Conclusion 
Despite several dosimetric differences among planning studies, 
the common agreement was that VMAT requires less number 
of MUs and shorter delivery time when compared to the IMRT. 
In comparison to the DA, the SA was more efficient in terms of 
beam delivery and MUs. The partial arc technique could 
provide dosimetric advantage over standard arc technique 
(with full gantry rotation) for the prostate cancer.  
Abbreviations 
CDR = Constant dose rate  
CTV = Clinical target volume  
DA = Double Arc 
EBRT = External beam radiation therapy  
IMRT = Intensity modulated radiation therapy  
MLC = Multi leaf collimator 
MUs = Monitor Units 
NTCP = normal tissue complication probability  
OAR = Organs at risk 
p-DA = Partial-Double Arc 
p-SA = Partial-Single Arc 
PTV = Planning target volume 
SA = Single Arc 
SIB = Simultaneous integrated boost  
TCP = Tumor control probability  
TPS = Treatment planning systems  
V70Gy = Relative volume of the structure receiving 70 Gy 
VDR = Variable-dose rate 
VMAT = Volumetric Intensity-Modulated Arc Therapy 
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